Biophytis SA Sponsored ADR BPTSY
0.25
0.00
0.00%
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow BPTSY
Growth Flags
show if company had growth for consecutive years
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.25 | 0.72 | 0.96 | 1.37 | 1.31 | 0.75 | 2.34 | 5.95 | 2.02 |
Net Debt/EBITDA |
(1.24) | (0.18) | (0.13) | 0.25 | 1.04 | (0.42) | 0.44 | 1.61 | 0.21 |
Debt/Assets |
142.60% | 69.15% | 66.31% | 51.47% | 33.43% | 79.23% | 32.05% | 0.00% | 12.98% |
Debt/Equity |
(1.01) | (2.13) | (7.63) | 3.27 | 1.33 | (1.85) | 1.00 | 0.01 | 0.24 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.83 | 0.76 | 0.78 | 0.76 | 0.58 | 0.92 | 0.91 | 0.76 | 0.83 |
Capex/Depreciation |
0.01 | (0.20) | (0.17) | (0.69) | (0.05) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 152.74% | 592.38% | (1,077.40%) | (508.01%) | 5,835.11% | 9,235.28% | (95.69%) | (90.58%) | (55.17%) | |
| (110.04%) | (102.06%) | (77.24%) | (99.93%) | (76.56%) | (89.06%) | (128.21%) | (311.18%) | (41.76%) | |
ROIC |
0.00% | 0.00% | (1,417.57%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
90.63% | 532.07% | 12,879.35% | (342.95%) | (295.72%) | 373.07% | (123.05%) | (57.60%) | (244.36%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.38 | 0.22 | 0.12 | 0.08 | 0.10 | 0.14 | 0.09 | 0.00 | 0.25 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — |
Free Cash Flow per Share |
(180.00) | (104.35) | (461.20) | (964.83) | (767.48) | (36.63) | (36.96) | (6.63) | (8.42) |
Cash per Share |
5.59 | 47.30 | 280.71 | 1,005.44 | 1,429.47 | 14.20 | 41.68 | 15.10 | 3.90 |
Shareholders Equity per Share |
(202.28) | (30.99) | (46.07) | 228.03 | 520.28 | (16.89) | 20.23 | 16.13 | 5.79 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(202.28) | (30.99) | (46.07) | 228.03 | 520.28 | (16.89) | 20.23 | 16.13 | 5.79 |
Free Cash Flow |
(9.34) | (14.17) | (20.15) | (28.56) | (11.51) | (18.37) | (14.68) | (10.51) | (6.96) |
Working Capital |
(12.64) | (3.80) | (0.81) | 10.11 | 6.46 | (5.57) | 12.73 | 23.49 | 3.14 |
Capital Expenditures |
0.01 | (0.24) | (0.15) | (0.41) | (0.24) | (0.32) | (0.13) | (0.15) | (0.14) |
Net Current Asset Value |
(13.72) | (7.57) | (5.61) | 1.34 | 4.15 | (11.79) | 5.17 | 22.50 | 2.12 |
| Other line items | |||||||||
Quick Ratio |
0.25 | 0.72 | 0.96 | 1.37 | 1.31 | 0.72 | 2.28 | 5.87 | 1.93 |
Depreciation/Fixed assets |
3.24 | 3.41 | 1.45 | 0.88 | 40.83 | 1.42 | 0.77 | 0.65 | 0.61 |
Cash ROIC |
(2,174.50%) | (127.84%) | (80.50%) | (49.19%) | (28.76%) | (129.56%) | (46.03%) | (21.93%) | (79.17%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.12 | 0.00 | 0.08 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,678.43 | 3,233.77 | 0.00 | 4,196.41 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 244.79 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(180.20) | (102.60) | (457.80) | (951.08) | (751.18) | (36.63) | (36.96) | (6.63) | (8.42) |
Capex per Share |
0.21 | (1.75) | (3.40) | (13.75) | (16.30) | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3.56 | 5.23 | 7.52 | 6.86 | 7.36 | 6.97 | 4.57 | 3.32 | 3.32 |
Average Payables |
5.23 | 6.57 | 8.16 | 9.06 | 6.04 | 2.64 | 2.17 | — | 2.17 |
Average Assets |
10.21 | 18.05 | 33.03 | 36.99 | 25.44 | 22.44 | 12.54 | 4.42 | 20.05 |
Average Common Equity |
(7.35) | (3.11) | 2.37 | 7.28 | (0.33) | (0.22) | 16.80 | 15.18 | 15.18 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates